RRD News and Press, R.R. Donnelley & Sons Company From 09/01/21

Chatham Asset Management Sends Letter to R.R. Donnelley Board of Directors Regarding Extension of Stockholder Rights Plan Board Renewed Entrenching Poison Pill Despite Objections of Shareholders and Leading Independent Proxy Advisory Firm ISS RRD Common Stock Price Has Decre...

Overview of the poison pill. Analysis of Chatham Asset Management's options going forward and outcomes for investors. Potential impacts on RRD stock price both near and long term. For further details see: R. R. Donnelley - Extension Of Rights Plan And Potential Impacts ...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Schools of every size and at every level can gain the communications agility necessary to drive recruitment efforts, academic engagement, student community, and safety R.R. Donnelley & Sons Company (RRD) (NYSE: RRD), a leading global provider of marketing and busines...

The following slide deck was published by R. R. Donnelley & Sons Company in conjunction with their 2021 Q2 earnings call. For further details see: R. R. Donnelley & Sons Company 2021 Q2 - Results - Earnings Call Presentation

R. R. Donnelley & Sons Company (RRD) Q2 2021 Earnings Conference Call August 04, 2021 11:00 AM ET Company Participants Johan Nystedt - Senior Vice President, Finance Dan Knotts - President & Chief Executive Officer Terry Peterson - Chief Financial Officer Conference Call Participants ...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

R.R. Donnelley & Sons (NYSE:RRD): Q2 Non-GAAP EPS of $0.07; GAAP EPS of -$0.13 misses by $0.09. Revenue of $1.15B (-0.9% Y/Y) beats by $30M. GAAP operating margin improved 440 bps while Non-GAAP improved by 150 bps, driven by leverage on increased sales volumes and aggressive cost-out act...

NET SALES GROWTH OF 13% NEAR TOP END OF PREVIOUS GUIDANCE INCOME FROM OPERATIONS IMPROVEMENT EXCEEDED PREVIOUS OUTLOOK; EPS ALSO UP SIGNIFICANTLY OVER PRIOR YEAR TOTAL DEBT DOWN $494 MILLION FROM A YEAR AGO COMPANY ISSUES IMPROVED FULL YEAR OUTLOOK R....